National Programme Serbia Against Cancer

Objectives

Establish a comprehensive national framework for cancer prevention and control in Serbia, responding to a substantial and rising cancer burden and seeking to reduce incidence and mortality, extend life expectancy, and improve the quality of life of patients and their families.[1][2][3][4]The programme applies an integrated, multisectoral approach across prevention, early detection, diagnosis, treatment, rehabilitation, palliative care, psychosocial support, education and research.[5][6]

• Reduce exposure to modifiable risks, including tobacco use, harmful alcohol consumption, unhealthy diet, physical inactivity, obesity, infections, excessive ultraviolet and other radiation, and carcinogenic agents in living and working environments.[5][7][8][9]
• Promote healthy behaviour, public education and health-protective environments, recognising primary prevention as capable of preventing up to two-thirds of cancer cases.[10][7]
• Expand organised early detection and screening for breast, cervical and colorectal cancer, promote recognition of symptoms, and provide genetic testing and counselling for people with inherited cancer predisposition.[11][12][13][14]
• Ensure timely diagnosis, prompt referral and equitable access to evidence-based, multidisciplinary treatment, with the aims of cure, longer survival, functional recovery and better quality of life.[15][16][17]
• Provide rehabilitation, supportive therapy, palliative care and psychosocial support from diagnosis through the end of life, addressing symptoms, treatment effects and the needs of families.[11][18][19]
• Strengthen oncology education, public awareness and translational, genetic, biological and clinical research to improve prevention, detection, prognosis, treatment selection and follow-up.[20][21][22][23]

Implementation

Implement the National Cancer Control Programme through coordinated action by health services, public-health bodies, government sectors, educational institutions, employers, civil society and communities.[5][2][24]The approach combines population-wide prevention with risk-based screening and diagnostics, multidisciplinary specialist care, referral networks, registry-based monitoring, professional education and research.[6][25][26]

• Coordinate programme implementation through a National Cancer Office within the Ministry of Health, responsible to the Minister and charged with coordinating participants, national protocols, guidelines, standards and plans, as well as prevention, diagnosis and treatment programmes.[27]
• Support the Republic Commission for Cancer and the Republic Expert Commission for Oncology in programme coordination, integration, oversight and proposals for improvement.[27][26]
• Deliver services across primary, secondary and tertiary care through health centres, hospitals, clinics, institutes, clinical centres and public-health institutes, using designated hospital capacities and daily hospitals where appropriate.[25]
• Designate reference institutions for comprehensive multidisciplinary oncology treatment, link other treating institutions organisationally and methodologically to them, and supervise implementation of approved protocols.[27]
• Use multidisciplinary teams involving relevant clinical specialists, general practitioners, gynaecologists, diagnosticians and radiologists, with therapeutic decisions made through appropriately appointed specialist committees.[25][15]
• Apply evidence-based diagnostic and treatment protocols aligned with international professional recommendations, using surgery, radiotherapy, chemotherapy, hormonal and other therapies, and psychosocial support according to clinical need.[15][16][28]
• Strengthen service capacity by increasing diagnostic and radiotherapy facilities and equipment, developing genetic-testing laboratories and counselling services, and supporting access to expensive and innovative medicines subject to relevant approvals.[14][18]
• Implement prevention through media and educational campaigns, smoke-free public places and workplaces, tobacco-sales restrictions for minors, food and health standards, immunisation and infection-prevention measures, occupational monitoring, environmental risk assessment and remediation of contaminated sites.[7][8][9][12]
• Deliver screening through national breast, cervical and colorectal programmes supported by public and health-worker education, suitable staffing and equipment.[13][14]Planned coverage includes screening 45% of women aged 45 to 69 for breast cancer, 75% of women aged 25 to 69 for cervical cancer, and faecal occult blood testing for 40% of average-risk women and men aged 50 to 70.[11]
• Maintain the cancer registry as a population-wide monitoring system, improve reporting, and establish a national register of families with inherited cancer predisposition.[20][14]
• Monitor outcomes including cancer mortality reduction, prevention of malignant disease, patient quality of life, screening coverage, and public knowledge and attitudes towards risk factors.[26]Evaluate annual work plans and oncology-service performance at all healthcare levels.[26]
• Require public-health institutes to report work plans and implementation to the Institute of Public Health of Serbia “Dr Milan Jovanović Batut” and the Office.[26]
• Finance implementation from the Republic of Serbia budget, with annual allocations determined by available resources and planned annual activities; the source does not specify monetary amounts or detailed budget lines.[26]

Monitoring & Evaluation

The programme combines population health surveillance, cancer-registry improvement, screening targets, occupational and environmental monitoring, service-performance review and annual reporting. Oversight is centred on the National Cancer Office within the Ministry of Health, the Institute of Public Health of Serbia Dr Milan Jovanović Batut, public-health institutes and the Republic Expert Commission for Oncology.[27][26]

• Use cancer mortality, incidence, crude mortality and European-standardised mortality rates to describe the cancer burden and monitor trends. Reported baseline data include 20,217 deaths from malignant tumours in 2006, an overall standardised mortality rate of 202.7 per 100,000 population, and higher mortality in Vojvodina than in the rest of Serbia excluding Kosovo and Metohija.[29]
• Monitor cancer incidence through data attributed to the Statistical Office of the Republic of Serbia and the Institute of Public Health of Serbia Dr Milan Jovanović Batut. Between 1999 and 2005, incidence rose from 321.3 to 391.5 per 100,000 among men and from 276.3 to 322.7 per 100,000 among women.[30]
• Maintain and improve the existing population-wide cancer registry, including its reporting, and evaluate the registry as part of the National Cancer Office’s responsibilities.[20][27]
• Track outcomes including reductions in cancer mortality and prevention of malignant diseases, patients’ quality of life, screening coverage, and changes in public knowledge and attitudes towards cancer risk factors.[26]
• Apply screening targets of 45% of women aged 45 to 69 for breast cancer, 75% of women aged 25 to 69 for cervical cancer, and faecal occult blood testing for 40% of average-risk men and women aged 50 to 70 for colorectal cancer.[11]
• Monitor tobacco-control progress through population tobacco-use indicators, and develop mechanisms to monitor workers exposed to carcinogenic risks and carcinogenic substances in workplaces.[8][9]
• Include pollution monitoring within environmental protection activities and maintain a national register of families with inherited cancer predisposition.[12][14]
• Assess treatment against outcomes of cure, prolonged survival, improved quality of life, absence of disease signs and symptoms, lower recurrence risk, and restored functional health.[15][16]
• Review annual work plans and the performance of oncology services at primary, secondary and tertiary care levels.[26]
• Require public-health institutes to report work plans and implementation to the Institute of Public Health of Serbia Dr Milan Jovanović Batut and the Office, while the Republic Expert Commission for Oncology evaluates programme integration and implementation and proposes improvements.[26]
• Use the National Cancer Office to coordinate and oversee prevention, diagnosis and treatment, monitor implementation of protocols in healthcare institutions, and support the Republic Commission for Cancer.[27]

Several sections identify monitoring and evaluation as part of an integrated implementation approach, but do not define a comprehensive indicator set, baselines and targets for all actions, reporting frequency, evaluation design, or detailed accountability procedures.[4][6][17][18]

Costing & Financing

Programme implementation is to be financed from the budget of the Republic of Serbia, with annual allocations determined by available resources and the activities planned for the relevant year.[26]

• Allocate annual resources according to the dynamics of funds available and the planned annual programme of activities.[26]
• Provide resources for screening equipment and staffing, genetic-testing laboratories, genetic counselling, expanded diagnostic and radiotherapy facilities, and equitable access to expensive and innovative medicines subject to Commission requirements and approval by the relevant authorities.[13][14][18]
• Use existing secondary- and tertiary-level institutional capacities, including daily hospitals, for cancer treatment where designated under health-care network regulations.[25]
• Develop technical and human-resource capacity for translational oncology research, without a stated monetary valuation.[22]
• Provide financial compensation for a parent taking special leave to care for a child with malignant disease, although no amount or financing arrangement is specified.[24]

No monetary programme budget, unit cost, budget line, funding gap, external financing source, resource-mobilisation mechanism or economic assumption is specified in the supplied material.[26][18]